Thus, evidence indicates that miR-153 contributes to post-transcriptional regulation of APP/APLP2 and may therefore have a role in Alzheimer's disease, although further validation of this potential interaction is required. This evidence concerns the gene APLP2 and early-onset autosomal dominant Alzheimer disease.